Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
23 Νοεμβρίου 2023
Kowdley et al NEJM 2023. Nov 13. doi: 10.1056/NEJMoa2306185 Πατώντας ΕΔΩ μπορείτε να δείτε το άρθρο
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement
18 Οκτωβρίου 2023
Transplant International 36:11729. DOI: 10.3389/ti.2023.11729 https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11729/full Δείτε ΕΔΩ το άρθρο.
Patient-reported quality of care in primary sclerosing cholangitis
26 Αυγούστου 2023
Walmsley M, et al. Liver International. 2023;43:1654–1662. DOI: 10.1111/liv.15650 Δείτε ΕΔΩ την περίληψη του άρθρου
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
12 Ιουλίου 2023
Murillo Perez, et al. Liver International. 2023;43:1497–1506. DOI: 10.1111/liv.15592 Δείτε ΕΔΩ το άρθρο
Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis
11 Ιουλίου 2023
Kowdley KV, et al. Am J Gastroenterol 2023;118:232–242. https://doi.org/10.14309/ajg.0000000000002070. Δείτε ΕΔΩ το άρθρο